Jonathan Arango - 20 Mar 2023 Form 3 Insider Report for MANGOCEUTICALS, INC. (MGRX)

Role
President, COO and Secretary, Director
Signature
/s/ Jonathan Arango
Issuer symbol
MGRX
Transactions as of
20 Mar 2023
Net transactions value
$0
Form type
3
Filing time
20 Mar 2023, 18:23:28 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MGRX Common Stock 1,000,000 20 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MGRX Stock Option (Right to Buy) 20 Mar 2023 Common Stock 500,000 $1.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 A total of 1/3 of such options vest on each of September 1, 2023, 2024 and 2025, subject to the Reporting Person's continued service with the Compan on such dates.